Cargando…
Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations
In a French national cohort of unaffected females carriers/non-carriers of a BRCA1/2 mutation, long-term preventive strategies and breast/ovarian cancer risk perceptions were followed up to 5 years after test result disclosure, using self-administered questionnaires. Response rate was 74%. Carriers...
Autores principales: | Julian-Reynier, Claire, Mancini, Julien, Mouret-Fourme, Emmanuelle, Gauthier-Villars, Marion, Bonadona, Valérie, Berthet, Pascaline, Fricker, Jean-Pierre, Caron, Olivier, Luporsi, Elisabeth, Noguès, Catherine |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083622/ https://www.ncbi.nlm.nih.gov/pubmed/21267012 http://dx.doi.org/10.1038/ejhg.2010.241 |
Ejemplares similares
-
Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO)
por: Lecarpentier, Julie, et al.
Publicado: (2012) -
BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis
por: Julian-Reynier, Claire, et al.
Publicado: (2012) -
Disclosure of research results: a randomized study on GENEPSO‐PS cohort participants
por: Mancini, Julien, et al.
Publicado: (2015) -
GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers
por: Lesueur, Fabienne, et al.
Publicado: (2018) -
Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2
por: Blein, Sophie, et al.
Publicado: (2015)